Document is current
Any future updates will be listed below
-
Authors
De Luca, Maurizio
Zese, Monica https://orcid.org/0000-0002-4768-6746
Silverii, Giovanni Antonio
Ragghianti, Benedetta
Bandini, Giulia
Forestieri, Pietro
Zappa, Marco Antonio
Navarra, Giuseppe
Foschi, Diego
Musella, Mario
Sarro, Giuliano
Pilone, Vincenzo
Facchiano, Enrico
Foletto, Mirto
Olmi, Stefano
Raffelli, Marco
Bellini, Rosario
Gentileschi, Paolo
Cerbone, Maria Rosaria
Grandone, Ilenia
Berardi, Giovanna
Di Lorenzo, Nicola
Lucchese, Marcello
Piazza, Luigi
Casella, Giovanni
Manno, Emilio
Zaccaroni, Alberto
Balani, Alessandro
Mannucci, Edoardo
Monami, Matteo
- License Information
-
More Information
Article History
Received: 18 August 2023
Revised: 13 October 2023
Accepted: 18 October 2023
First Online: 2 November 2023
Declarations
:
: Not applicable.
: Matteo Monami has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Bristol Myers Squibb. Edoardo Mannucci has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Merck, Novartis, and Takeda. Maurizio De Luca, Monica Zese, Giovanni Antonio Silverii, Benedetta Ragghianti, Giulia Bandini, Pietro Forestieri, Marco Antonio Zappa, Giuseppe Navarra, Diego Foschi, Mario Musella, Giuliano Sarro, Vincenzo Pilone, Enrico Facchiano, Mirto Foletto, Stefano Olmi, Marco Raffelli, Rosario Bellini, Paolo Gentileschi, Maria Rosaria Cerbone, Ilenia Grandone, Giovanna Berardi, Nicola Di Lorenzo, Marcello Lucchese, Luigi Piazza, Giovanni Casella, Emilio Manno, Alberto Zaccaroni, Alessandro Balani has no conflicts of interest to declare.
